Ekso Bionics Holdings, Inc. (EKSO)

7.91 +0.06 (+0.76%) USD  |  NASDAQ  |  Jan 22, 16:00
8.01 +0.10 (+1.26%) After-Hours: 20:00
More

Ekso Bionics Holdings Research and Development Expense (TTM): 3.235M for Sept. 30, 2025

Research and Development Expense (TTM) Chart

View Research and Development Expense (TTM) for EKSO.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (TTM) Range, Past 5 Years

View Research and Development Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (TTM) Benchmarks

View Research and Development Expense (TTM) Benchmarks
Start Trial
Autonomix Medical, Inc. 6.557M
Perspective Therapeutics, Inc. 61.22M
InfuSystem Holdings, Inc. --
Xtant Medical Holdings, Inc. 2.165M
VolitionRX Ltd. 9.144M